Cytokinetics Starts Phase 2 Clinical Trial Therapy for COPD Patients
COPD, News
Cytokinetics, a biopharma company that develops muscle activators as potential treatments for certain debilitating diseases, has launched a clinical trial evaluating the efficacy, safety, tolerability, and pharmacokinetics of CK-107 in the ... Read more